Quantum Immunologics, Inc. ("QI"), a Tampa-based company currently engaged in an FDA-authorized clinical study of its autologous dendritic cell immunotherapy for Stage IV breast cancer patients.
Recently announced that it has been awarded approval for each of three grant applications relating to the US Government's Qualifying Therapeutics Disc ...
Satisfied Users & 
Approved Press Releases
